Ting Dong

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Separation technologiesPredictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity.

Yi Zheng, Fan Yang, Mengmeng Wang

|Mar 19, 2026
An orthogonal RNA aptamer for targeted RNA regulation in phase-separated subcellular compartments.

Jingcheng Wang, Kaicheng Ma, Xiaomeng Cao

|Jan 20, 2026
Calumenin prevents fibroblast senescence and lung aging by promoting vimentin proteostasis.

Ting Dong, Xue Jiao, Huirui Wang

|Jul 31, 2025
Stress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging.

Ting Dong, Nianyu Li, Huirui Wang

|Oct 16, 2024
Targeting VPS18 hampers retromer trafficking of PD-L1 and augments immunotherapy.

Ting Dong, Huanmin Niu, Zhaojun Chu

|Sep 19, 2024
MFSD7C protects hemolysis-induced lung impairments by inhibiting ferroptosis.

Huirui Wang, Xiaona You, Jingcheng Wang

Pageof 1

Frequent Collaborators

4 joint publications

Hongxiang Lou

3 joint publications

Huirui Wang

2 joint publications

Hui Li

2 joint publications

Xiaohui Liu